home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Premarket Review of New and Modified Tobacco Products

 
  October 08, 2013  
     
 
ComplianceOnline, Online Event
2013-10-24


Why Should You Attend:

On June 12, 2009, the Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act) became law, and amended the Federal Food, Drug and Cosmetic Act to give the Agency authority to regulate the manufacture, labeling, distribution, and marketing of tobacco products in the United States.

To bring a “new” tobacco product to the market will require obtaining FDA pre-market authorization by either demonstrating that the new product is substantially equivalent to a predicate product that was on the market as of the “Grandfather Date,” or submitting a new tobacco product application pursuant to Section 910 of the Tobacco Control Act. Companies looking to market their products with claims of either “reduced risk” or “reduced exposure” will need to prepare and submit a Section 911 Modified Risk Tobacco Product application to FDA. These premarket authorization requirements for now and modified risk tobacco products will also likely apply to currently unregulated products, such as e-cigarettes, once those products are captured within FDA’s authority pursuant to the upcoming Deeming Regulation.

This webinar will focus on FDA’s regulatory requirements of new and modified tobacco products. The instructor will discuss premarket authorization requirements including Section 910 new tobacco product application and Section 905(j) substantial equivalence report.

Areas Covered in the Webinar:

  • Premarket Review of New and Modified Tobacco Products
  • Section 910 New Tobacco Product Application
  • Section 905(j) Substantial Equivalence Report
  • Section 905(j)(3) Minor Modification Exemption
  • Section 911 Modified Risk Tobacco Product Application
  • What E-Cigarettes and Other Tobacco Products Can Expect
 
 
Organized by: ComplianceOnline
Invited Speakers: Azim Chowdhury, joined Keller and Heckman in 2010 and practices in the area of food and drug law. Mr. Chowdhury advises domestic and foreign corporations in matters of FDA and international regulatory compliance. In particular, he assists corporations in establishing clearances for food and drug additives in the U.S., Canada, and European Union, with an emphasis on indirect additives used in food-contact materials.
 
Deadline for Abstracts: 2013-10-24
 
Registration: http://www.complianceonline.com/ecommerce/control/trainingFocus/~product_id=703127?channel=hummolgen
E-mail: referral@complianceonline.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.